key: cord-1018356-4b6iwfa3 authors: Mak, Gannon C. K.; Lau, Angela W. L.; Chan, Andy M. Y.; Lam, Edman T. K.; Chan, Rickjason C. W.; Tsang, Dominic N. C. title: The surveillance of spike protein for patients with COVID‐19 detected in Hong Kong in 2020 date: 2021-05-24 journal: J Med Virol DOI: 10.1002/jmv.27063 sha: ddc3445fe65edd837427dc7c6d555f3c04e2bc3b doc_id: 1018356 cord_uid: 4b6iwfa3 In 2020, numerous fast‐spreading severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants have been reported. These variants had unusually high genetic changes in the spike (S) protein. In an attempt to understand the genetic background of SARS‐CoV‐2 viruses in Hong Kong, especially before vaccination, the purpose of this study is to summarize the S protein mutations detected among coronavirus disease 2019 (COVID‐19) patients in Hong Kong in 2020. COVID‐19 cases were selected every month in 2020. One virus from each case was analyzed. The full encoding region of the S proteins was sequenced. From January 2020 to December 2020, a total of 340 COVID‐19 viruses were sequenced. The amino acids of the S protein for 44 (12.9%) were identical to the reference sequence, WIV04 (GenBank accession MN996528). For the remaining 296 sequences (87.1%), a total of 43 nonsynonymous substitution patterns were found. Of the nonsynonymous substitutions found, some of them were only detected at specific time intervals and then they disappeared. The ongoing genetic surveillance system is important. It would facilitate early detection of mutations that can increase infectivity as well as mutations that are selected for the virus to escape immunological restraint. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV -2) has been spreading around the world since 2019 and variants harboring various mutations have been increasingly identified (henceforth: "variant" stands for virus with one or more mutations that are different from the original virus 1 ). Several of the mutations, especially those in the receptor-binding domain, were associated with enhanced affinity to the receptor in humans. Preliminary findings showed that they were fast-spreading variants. These variants shared common features, notably high genetic changes in the spike (S) protein, 2-6 which is a key target for vaccine, virus entry, and infectivity. 7 In Hong Kong, the SARS-CoV-2 vaccine was available by end of February 2021 for the public free of charge. 8 Genetic surveillance would facilitate early detection of mutations that can increase infectivity as well as mutations that are selected for the virus to escape immunological restraint, especially when the vaccine is available. The purpose of this study is to summarize the S protein mutations detected among COVID-19 patients in Hong Kong in 2020. We focused our study on the SARS-CoV-2 S protein to characterize viral mutations that are potentially associated with neutralization and immunity. It also served the purpose of knowing the genetic background of SARS-CoV-2 viruses in Hong Kong before the launch of vaccination. With the exception of May and June 2020 when five and six COVID-19 cases were selected respectively due to a low number of COVID-19 cases, at least ten COVID-19 cases were selected every month in 2020. COVID-19 cases were selected in different time points to achieve a balanced representation and to avoid selection bias. The protocols were based on the previous study. 9 Only one virus from each case was analyzed. The S protein consists of 1273 amino acids; the full encoding region of 3822 nucleotides (from start to stop codons) was analyzed for each virus. Epidemiological information was collected as described. 10 (Table 1) . Excluding the three viruses that harbored ≥10 nonsynonymous substitutions, an average of 1.60 nonsynonymous substitutions were found for the 293 viruses. For these 293 viruses, when compared with the number of nonsynonymous substitutions among imported cases (N = 70) and local cases (N = 223), statistical differences were not found for these two groups of viruses (unpaired t test, The number of nonsynonymous substitutions observed was unusually high for those three viruses. These two thresholds accounted for 0.31% (4/1273) and 0.78% (10/1273) of amino acid changes, respectively. A total of 43 nonsynonymous substitution patterns were found, 33 (76.7%) of them were detected only once (Table S1 ). Although these 33 sequences were only sequenced once, (Table S2 ). The S gene nucleotide sequences generated in this study have been deposited in the Global Initiative for Sharing All Influenza Data (GISAID) database. The corresponding patient information is also available in Table S3 . In Hong Kong, the first COVID-19 case was detected from respiratory samples collected from a man on January 22, 2020. A total of 8847 COVID-19 cases were detected in 2020. Regarding the number of cases confirmed daily, three peaks were observed, namely during March-April 2020, July-August 2020, and November-December 2020. 11 Each peak was characterized by consecutive daily reported cases of ≥10. In this study, we analyzed 12 The 12F was detected from July to September 2020, it coincided with the peak observed during July 2020. This finding was concordant with the genome study performed by another research group in Hong Kong. 13 The 614G was first detected in Mar 2020 and since then its proportion had increased from 50.0% (11/22) however, the significance of other mutations remained to be determined. [3] [4] [5] Our data show that, over the 1-year period of 2020, the mutations of S protein harbored by each virus were few overall. The low genetic diversity of the S protein might be due to the lack of immunological pressure. Although dominating variants were found in different time periods, they were only detected for few months. The genetic diversity of the S protein is still being determined after vaccination. Laboratory surveillance to monitor variants of SARS-CoV-2 is important. It is common that laboratories use specific PCR assays to track the signature mutations in variants. Coincidentally, variants identified in UK, South Africa and Brazil shared 501Y. [2] [3] [4] However, these assays should be used with cautions. It is not known whether new variants will harbor novel mutations in the S protein or other regions. 19, 20 It is expected that the SARS-CoV-2 is likely to become an endemic infection. To track variants, a surveillance system should be implemented in addition to monitoring mutations in the S protein. We thank our colleagues Alan K.L. Tsang, Peter C.W. Yip, and Peter K.C. Cheng for technical assistance in identifying variants during the current SARS-CoV-2 pandemic. The effects of virus variants on COVID-19 vaccines COVID mink analysis shows mutations are not dangerous -yet Investigation of novel SARS-CoV-2 variant Variant of Concern 202012/01. Version 1, release date 21/122020 Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. bioRxivorg Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil Emergence of a novel SARS-CoV-2 variant in Southern California Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein The Government of the Hong Kong Special Administrative Region. COVID-19 Vaccination Programme The D614G substitution in the S gene and clinical information for patients with COVID-19 detected in Hong Kong The epidemiology of COVID-19 cases and the successful containment strategy in Hong Kong Latest situation of cases of COVID-19 Territorywide study of early coronavirus disease outbreak Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong? Covid-19: Gov′t barring Hongkongers returning from UK, despite earlier stance on returnees from China Radio Television Hong Kong. HK sees first mutant Covid strain from South Africa Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant Emergence of a severe acute respiratory syndrome coronavirus 2 virus variant with novel genomic architecture in Hong Kong The surveillance of spike protein for patients with COVID-19 detected in Hong Kong in 2020 The authors declare that there are no conflict of interests.AUTHOR CONTRIBUTIONS Gannon C. K. Mak: conceptualized the study design, led the data collection, data analysis, data interpretation, and manuscript writing. The data that support the findings of this study are available in the supplementary material of this article.